AstraZeneca to resume coronavirus vaccine trial after unexplained illness in U.K. The United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials after a brief pause. AstraZeneca paused trials earlier this week due to a potentially unexplained illness. : Health

AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concerns

The United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials after a brief pause. 

AstraZeneca paused trials earlier this week due to a potentially unexplained illness. 

CEO Pascal Soriot said during a private conference call that the illness occurred in a woman in the U.K. who displayed neurological symptoms consistent with a spinal inflammatory disorder called transverse myelitis.   

Illnesses often occur by chance in large trials but are investigated out of an abundance of caution.